Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy

Abstract Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing proce...

Full description

Bibliographic Details
Main Authors: Oscar Fabian Garcia-Aponte, Christoph Herwig, Bence Kozma
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Journal of Biological Engineering
Subjects:
Online Access:https://doi.org/10.1186/s13036-021-00264-7
id doaj-08f4f138bc094a688e4cf85ab8ba3e0c
record_format Article
spelling doaj-08f4f138bc094a688e4cf85ab8ba3e0c2021-04-18T11:27:44ZengBMCJournal of Biological Engineering1754-16112021-04-0115113410.1186/s13036-021-00264-7Lymphocyte expansion in bioreactors: upgrading adoptive cell therapyOscar Fabian Garcia-Aponte0Christoph Herwig1Bence Kozma2Research Area Biochemical Engineering, Institute of Chemical, Environmental and Bioscience Engineering, TU WienResearch Area Biochemical Engineering, Institute of Chemical, Environmental and Bioscience Engineering, TU WienResearch Area Biochemical Engineering, Institute of Chemical, Environmental and Bioscience Engineering, TU WienAbstract Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing process that is able to control cell growth and functionality towards therapy affordability and opportunity. In this review, we discuss and compare current bioreactor technologies by performing a systematic analysis of the published data on automated lymphocyte expansion for adoptive cell therapy. We propose a set of requirements for bioreactor design and identify trends on the applicability of these technologies, highlighting the specific challenges and major advancements for each one of the current approaches of expansion along with the opportunities that lie in process intensification. We conclude on the necessity to develop targeted solutions specially tailored for the specific stimulation, supplementation and micro-environmental needs of lymphocytes’ cultures, and the benefit of applying knowledge-based tools for process control and predictability.https://doi.org/10.1186/s13036-021-00264-7Adoptive cell therapyATMPBioreactorExpansionLymphocyteRocking motion
collection DOAJ
language English
format Article
sources DOAJ
author Oscar Fabian Garcia-Aponte
Christoph Herwig
Bence Kozma
spellingShingle Oscar Fabian Garcia-Aponte
Christoph Herwig
Bence Kozma
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
Journal of Biological Engineering
Adoptive cell therapy
ATMP
Bioreactor
Expansion
Lymphocyte
Rocking motion
author_facet Oscar Fabian Garcia-Aponte
Christoph Herwig
Bence Kozma
author_sort Oscar Fabian Garcia-Aponte
title Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
title_short Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
title_full Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
title_fullStr Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
title_full_unstemmed Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
title_sort lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
publisher BMC
series Journal of Biological Engineering
issn 1754-1611
publishDate 2021-04-01
description Abstract Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing process that is able to control cell growth and functionality towards therapy affordability and opportunity. In this review, we discuss and compare current bioreactor technologies by performing a systematic analysis of the published data on automated lymphocyte expansion for adoptive cell therapy. We propose a set of requirements for bioreactor design and identify trends on the applicability of these technologies, highlighting the specific challenges and major advancements for each one of the current approaches of expansion along with the opportunities that lie in process intensification. We conclude on the necessity to develop targeted solutions specially tailored for the specific stimulation, supplementation and micro-environmental needs of lymphocytes’ cultures, and the benefit of applying knowledge-based tools for process control and predictability.
topic Adoptive cell therapy
ATMP
Bioreactor
Expansion
Lymphocyte
Rocking motion
url https://doi.org/10.1186/s13036-021-00264-7
work_keys_str_mv AT oscarfabiangarciaaponte lymphocyteexpansioninbioreactorsupgradingadoptivecelltherapy
AT christophherwig lymphocyteexpansioninbioreactorsupgradingadoptivecelltherapy
AT bencekozma lymphocyteexpansioninbioreactorsupgradingadoptivecelltherapy
_version_ 1721522230529097728